About mLife

mLife was founded on the principal that toxicology point of care testing needs to change.  The status quo is a pain point across various end markets.  Urine and blood testing is too invasive, too slow and in certain environments not always possible.   mLife prides its self on delivering the the right results, at the right place and at the right time. 


Dr. Guirguis 

Chief Science Officer

One of the leading authorizes in the field of sample collection and POC testing.

  • University of Alexandria Egypt, MD and MS; Georgetown University, MS (bioengineering) and PhD (biophysics)

  • Served as a research pathologist at the National Cancer Institute/NIH, Bethesda, MD, and as a research associate at the Lombardi Cancer Center at Georgetown

  • Dr. Guirguis has several inventions and patents to his name in the fields of molecular diagnostics, cancer early detection and sample collection and testing:

    • Urine test in the cup (Genie-Cup™)

    • Saliva-based nanotechnology (colloidal gold) vertical-flow test strips for POC testing

    • Infra-Red monolayer cytology based cancer detection

    • Smart-vacutainer blood withdrawing and testing

    • Monolayer cytology from liquid preparation (MonoPrep™) for cervical and bladder cancer screening (replaced the traditional Pap smear methodology)

    • Dr. Guirguis’ technologies have been used by corporations including DuPont Bristol-Myers Squibb, MonoGen, Cytyc, Hologic, Point of Care Fingerprint Biotech, Syva, Dade Behring and Siemens